학술논문
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
Document Type
Article
Author
Bonfiglio, S.; Gandini, F.; Ranghetti, P.; Scarfò, L.; Ghia, P.; Sutton, L.-A.; Ljungström, V.; Foroughi-Asl, H.; Skaftason, A.; Cortese, D.; Rosenquist, R.; Pandzic, T.; Weström, S.; Baliakas, P.; Capasso, A.; Gellerbring, A.; Lyander, A.; Gaidano, G.; Trentin, L.; Bonello, L.; Coscia, M.; Reda, G.; Bödör, C.; Stavroyianni, N.; Tam, C.S.; Marasca, R.; Forconi, F.; Panayiotidis, P.; Ringshausen, I.; Jaksic, O.; Frustaci, A.M.; Iyengar, S.; Mulligan, S.P.; Ysebaert, L.; Strugov, V.; Pavlovsky, C.; Walewska, R.; Österborg, A.; Stamatopoulos, K.
Source
In: Blood Advances . (Blood Advances, June 2023, 7(12):2794-2806)
Subject
Language
English
ISSN
24739537
24739529
24739529